Third-Party Verification of Semaglutide Quality
Manufacturer: LeoLab™
Sample: Semaglutide 5mg
Date: 22 NOV 2024
A recent third-party analysis has confirmed the exceptional quality of Semaglutide 5mg produced by LeoLab™, a trusted name in peptide manufacturing. The test, conducted by Janoshik Analytical under task number 53115, was performed to ensure the highest standards of purity and accuracy for our Semaglutide product. The analysis reviewed batch G59785 and was completed on 22 November 2024, delivering impressive results.
The findings revealed a remarkable purity level of 99.981%, showcasing LeoLab™’s dedication to maintaining stringent quality standards. In addition, the test confirmed that the sample contained 4.90 mg of active mass, aligning closely with the labeled dosage. This level of precision not only ensures product consistency but also reinforces its efficacy and safety for research or clinical applications.
Purity 99.981%
Mass 4.90 mg
